Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

Share Price is delayed by 15 minutes
Get Live Data
896.00    -10.00 (-1.10%)
Bid:
890.00
Ask:
902.00
Spread: 12.00 (1.348%)
Market Cap: £19.02b
AIBG Live PriceLast checked at - London Stock Exchange

Intraday Aib Group Share Chart

AIB Group plc - SREP

26 Jan 2022 07:06

RNS Number : 6801Z
AIB Group PLC
26 January 2022
 

 

 

 

26 January 2022

AIB Group plc - SREP

 

 

Supervisory Review and Evaluation Process (SREP)

 

Following the Supervisory Review and Evaluation Process (SREP) performed by the ECB in 2021 and the re-introduction of the UK Countercyclical buffer in December 2022, the minimum requirement for the CET1 ratio for AIB Group plc (AIB) was set at 10.20% for FY 2022 (1) - see table below. The Pillar 2 Requirement reduced by 25bps to 2.75% from 3.00%.

 

AIB continues to have a very strong capital base with a fully loaded CET1 at September 2021 of 16.6%. The Group's reported capital ratios are materially in excess of minimum regulatory requirements and AIB continues to maintain a very significant buffer above maximum distributable amount (MDA) trigger levels.

 

AIB does not disclose Pillar 2 Guidance (P2G), however following the ECB's revised P2G methodology, AIB confirms it is in bucket 3 which has a P2G range of 1.00% - 2.75%.

 

The table below shows the total capital requirements of the Group and components based on an assumption of optimal usage of Tier 2 and AT1 instruments permitted under the Capital Requirements Regulation (CRR).

 

SREP Requirements

AIB SREP Requirement 2021

AIB SREP Requirement 2022

AIB SREP Requirement 2023

 

 

 

 

Pillar 1 CET1

4.50%

4.50%

4.50%

Pillar 2 Requirement (P2R) CET1 (2)

1.69%

1.55%

1.55%

Capital Conservation Buffer (CCB)

2.50%

2.50%

2.50%

Other Systemically Important Institutions Buffer (O-SII)

1.50%

1.50%

1.50%

Countercyclical buffer (CCyB) (3)

0.00%

0.15%

0.35%

Total CET 1 requirement

10.19%

10.20%

10.40%

AT1

2.06%

2.02%

2.02%

Tier 2

2.75%

2.69%

2.69%

Total Capital Requirement (1)

15.00%

14.90%

15.10%

(1) Excludes Pillar 2 Guidance (P2G)

(2) P2R of 2.75% of which 1.55% must be held in the form of CET1 assuming 52bps AT1 and 69bps Tier 2 to meet P2R requirement

(3) Countercyclical buffer - re-introduction of the UK CCyB at 1% in December 2022, rising to 2% in 2023. It is estimated to equate to a Group requirement of c.0.15% in 2022 and c. 0.35% in 2023.

 

     

Figures presented may be subject to rounding

 

For further information, please contact:

Niamh Hore

Siobhain Walsh

Head of Investor Relations

Head of Debt Investor Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-1-6411817

Tel: +353-1-6411901

email: niamh.a.hore@aib.ie

email: siobhain.m.walsh@aib.ie

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEESWMEESESF
Date   Source Headline
2nd Aug 20243:40 pmRNSHolding(s) in Company
2nd Aug 20247:00 amRNSHalf-Year Report 2024
24th Jul 20246:22 pmRNSHolding(s) in Company
16th Jul 20248:01 amRNSHolding(s) in Company
10th Jul 20241:54 pmRNSHolding(s) in Company
4th Jul 20242:46 pmRNSHolding(s) in Company
3rd Jul 20241:06 pmRNSHolding(s) in Company
28th Jun 20242:51 pmRNSHolding(s) in Company
27th Jun 20247:05 amRNSAIB Group plc - Statement on State Divestment
27th Jun 20247:00 amRNSDisposal of approximately 5% of AIB Group plc
11th Jun 202411:36 amRNSHolding(s) in Company
7th Jun 20244:12 pmRNSDirector/PDMR Shareholding
4th Jun 20248:58 amRNSHolding(s) in Company
31st May 202411:49 amRNSTotal Voting Rights
21st May 20244:55 pmRNSHolding(s) in Company
14th May 20248:25 amRNSStabilisation Notice
14th May 20247:00 amRNSDirector Declaration
14th May 20247:00 amRNSHolding(s) in Company
13th May 20241:10 pmRNSHolding(s) in Company
13th May 20247:59 amRNSStabilisation Notice
9th May 20245:11 pmRNSHolding(s) in Company
9th May 20244:53 pmRNSHolding(s) in Company
8th May 202410:33 amRNSTotal Voting Rights
7th May 20245:36 pmRNSHolding(s) in Company
7th May 20247:00 amRNSHolding(s) in Company
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20246:01 pmRNSResult of Meeting
2nd May 20246:00 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Statement
26th Apr 202410:13 amRNSRE EGM: Final Price in respect of Buyback Contract
24th Apr 20249:32 amRNSStabilisation Notice
23rd Apr 20245:16 pmRNSHolding(s) in Company
23rd Apr 20249:23 amRNSStabilisation Notice
3rd Apr 20243:00 pmRNSNotice of GM
3rd Apr 20243:00 pmRNSNotice of AGM
25th Mar 20248:34 amRNSHolding(s) in Company
11th Mar 20249:51 amRNSDirector/PDMR Shareholding
6th Mar 20247:15 amRNSDividend Declaration
6th Mar 20247:00 amRNS2023 Annual Financial Results Announcement
4th Mar 20244:25 pmRNSHolding(s) in Company
27th Feb 20242:23 pmRNSHolding(s) in Company
16th Feb 20243:35 pmRNSHolding(s) in Company
30th Jan 202412:36 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSFurther Renewal of the AIB share trading plan
14th Dec 20233:37 pmRNSHolding(s) in Company
11th Dec 20233:40 pmRNSHolding(s) in Company
24th Nov 20235:31 pmRNSHolding(s) in Company
8th Nov 20235:17 pmRNSHolding(s) in Company
8th Nov 202311:43 amRNSHolding(s) in Company
7th Nov 20235:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.